HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.

Abstract
Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity. Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behçet's disease, which is typically considered a polygenic disorder with onset in early adulthood. A20 is a potent inhibitor of the NF-κB signaling pathway. Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of IκBα and nuclear translocation of the NF-κB p65 subunit together with increased expression of NF-κB-mediated proinflammatory cytokines. A20 restricts NF-κB signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-κB-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.
AuthorsQing Zhou, Hongying Wang, Daniella M Schwartz, Monique Stoffels, Yong Hwan Park, Yuan Zhang, Dan Yang, Erkan Demirkaya, Masaki Takeuchi, Wanxia Li Tsai, Jonathan J Lyons, Xiaomin Yu, Claudia Ouyang, Celeste Chen, David T Chin, Kristien Zaal, Settara C Chandrasekharappa, Eric P Hanson, Zhen Yu, James C Mullikin, Sarfaraz A Hasni, Ingrid E Wertz, Amanda K Ombrello, Deborah L Stone, Patrycja Hoffmann, Anne Jones, Beverly K Barham, Helen L Leavis, Annet van Royen-Kerkof, Cailin Sibley, Ezgi D Batu, Ahmet Gül, Richard M Siegel, Manfred Boehm, Joshua D Milner, Seza Ozen, Massimo Gadina, JaeJin Chae, Ronald M Laxer, Daniel L Kastner, Ivona Aksentijevich
JournalNature genetics (Nat Genet) Vol. 48 Issue 1 Pg. 67-73 (01 2016) ISSN: 1546-1718 [Electronic] United States
PMID26642243 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • AGFG1 protein, human
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • IKBKG protein, human
  • Intracellular Signaling Peptides and Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Nuclear Pore Complex Proteins
  • Nuclear Proteins
  • RNA-Binding Proteins
  • TNF Receptor-Associated Factor 6
  • NF-KappaB Inhibitor alpha
  • I-kappa B Kinase
  • TNFAIP3 protein, human
  • Tumor Necrosis Factor alpha-Induced Protein 3
Topics
  • Age of Onset
  • DNA-Binding Proteins (genetics, metabolism)
  • Female
  • Haploinsufficiency (genetics)
  • Hereditary Autoinflammatory Diseases (genetics, metabolism)
  • Humans
  • I-kappa B Kinase (genetics, metabolism)
  • I-kappa B Proteins (genetics, metabolism)
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Male
  • Mutation
  • NF-KappaB Inhibitor alpha
  • NF-kappa B (genetics, metabolism)
  • Nuclear Pore Complex Proteins (genetics, metabolism)
  • Nuclear Proteins (genetics, metabolism)
  • Pedigree
  • RNA-Binding Proteins (genetics, metabolism)
  • TNF Receptor-Associated Factor 6 (genetics, metabolism)
  • Tumor Necrosis Factor alpha-Induced Protein 3

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: